CompletedNCT01452061
Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder
Observational studyAges 1–12United StatesADHD
Understand this study
Who was this study for?
Listed age limits: 1 year to 12 years.
- Listed locations
- Cleveland, United StatesSee all locations and recruitment
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateJanuary 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 456
- Sponsor
- Thomas W. Frazier, Ph.D
- Sponsor type
- Individual investigator
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 1 Year to 12 Years
- Official registry ID
- NCT01452061
- Official title
Show the full official title
Understanding Genetic Differences Associated With Autism Spectrum and Attention Deficit/Hyperactivity Disorder
Recruitment & locations
CompletedCleveland
Questions about this study
Who is behind this study?
The study sponsor is Thomas W. Frazier, Ph.D.
Who was this study for?
Listed age limits: 1 year to 12 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A comparison of lifestyle patterns in children with/without Attention Deficit Hyperactivity Disorder
A Naturalistic Study of Functional Impairment for Individuals With ADHD in the Early Morning and Late Afternoon/Evening Hours